You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 19 Next »

I. Suggested Operational Fix

No.ProponentTopicFileTentative Presentation Date
1Kristine Dorrain

B. NOTICE

3. Other topics

URS-Proposal-05 Sep 2018-5.pdf
2Maxim Alzoba

F. REMEDIES

2. Duration of Suspension Period

3. Review of Implementation

URS-Proposal-29 Aug 2018-1.pdf
3Zak Muscovitch

F. REMEDIES

2. Duration of Suspension Period

3. Review of Implementation

URS-Proposal-31 Aug 2018-2.pdf
4George Kirikos

F. REMEDIES

4. Other topics

URS-Proposal-27 Aug 2018-1.pdf

III. Other 

No.ProponentCategoryTopicDeferred to Phase 2FileTentative Presentation Date

George KirikosElimination of URS procedure entirely

N. ALTERNATIVE PROCESSES

1. Possible alternative(s) to the URS, e.g., summary procedure in the UDRP


URS-Proposal-05 Sep 2018-6.pdf

George KirikosURS and UDRP Providers themselves to be brought under contract with ICANN(no applicable subheading at present)YesURS-Proposal-06 Sep 2018-8.pdf


II. Draft Policy Recommendation 

No.ProponentTopic (Mapped to the Super Consolidated URS Topics Table)Phase 2 Topic?FileNotes
14George Kirikos

A. THE COMPLAINT

3. Limited filing period

YesURS-Proposal-05 Sep 2018-1.pdf
5David McAuley

A. THE COMPLAINT

8. Other topics


URS-Proposal-30 Aug 2018-1.pdf
28Claudio DiGangi

A. THE COMPLAINT

8. Other topics


URS-Proposal-06 Sep 2018-9.pdf
24George Kirikos

B. NOTICE

1. Receipt by registrant (Notice - feedback from Complainant & Respondent)

YesURS-Proposal-06 Sep 2018-5.pdf
13George Kirikos

C. RESPONSE

1. Duration of response period

YesURS-Proposal-04 Sep 2018-3.pdf
29Brian Winterfeldt; Christopher Thomas; Colin O’Brien; Griffin Barnett; Jeff Neuman; John McElwaine; Lori Schulman; Pascal Boehner; Paul McGrady; Susan Payne

C. RESPONSE

2. Other issues relating to Responses (other than issues relating to Defenses), e.g. Default procedures


URS-Proposal-06 Sep 2018-10.pdf
33Brian Winterfeldt; Christopher Thomas; Colin O’Brien; Griffin Barnett; Jeff Neuman; John McElwaine; Lori Schulman; Pascal Boehner; Paul McGrady; Susan Payne

C. RESPONSE

3. Response fee


URS-Proposal-06 Sep 2018-14.pdf
25George Kirikos

D. STANDARD OF PROOF

1. General

YesURS-Proposal-06 Sep 2018-6.pdf


















2George Kirikos

M. URS PROVIDERS

(no applicable subheading at present)


Yes
3George Kirikos

J. LANGUAGE ISSUES

1. Language issues, including current requirements for complaint, notice of complaint, response, determination



5





6Zak Muscovitch

J. LANGUAGE ISSUES

1. Language issues, including current requirements for complaint, notice of complaint, response, determination



8Zak Muscovitch

M. URS PROVIERS

1. Evaluation of URS providers and their respective processes (including training of panelists)



9Zak Muscovitch

M. URS PROVIERS

1. Evaluation of URS providers and their respective processes (including training of panelists)



10Zak Muscovitch

M. URS PROVIERS

2. Conflict of interest



11George Kirikos

I. COST

1. Cost allocation model

Yes
12George Kirikos

N. ALTERNATIVE PROCESSES

1. Possible alternative(s) to the URS, e.g. summary procedure in the UDRP

Yes









Yes



15George Kirikos

G. APPEAL

2. De novo review

YesRelated proposals
16George Kirikos

G. APPEAL

1. Appeals process

Yes
17George Kirikos

G. APPEAL

2. De novo review

Yes
20Marie Pattullo (AIM - European Brands Association)

F. REMEDIES

2. Duration of suspension period



21Marie Pattullo (AIM - European Brands Association)

I. COST

1. Cost allocation model



22Marie Pattullo (AIM - European Brands Association)

F. REMEDIES

1. Scope of remedies



23Marie Pattullo (AIM - European Brands Association)

F. REMEDIES

1. Scope of remedies















26David McAuley

G. APPEAL

2. De novo review















30Brian Winterfeldt; Christopher Thomas; Colin O’Brien; Griffin Barnett; Jeff Neuman; John McElwaine; Lori Schulman; Pascal Boehner; Paul McGrady; Susan Payne

F. REMEDIES

1. Scope of remedies



31Brian Winterfeldt; Christopher Thomas; Colin O’Brien; Griffin Barnett; Jeff Neuman; John McElwaine; Lori Schulman; Pascal Boehner; Paul McGrady; Susan Payne

I. COST

1. Cost allocation model



32Brian Winterfeldt; Christopher Thomas; Colin O’Brien; Griffin Barnett; Jeff Neuman; John McElwaine; Lori Schulman; Pascal Boehner; Paul McGrady; Susan Payne

F. REMEDIES

1. Scope of remedies

2. Duration of suspension period









  • No labels